Correlation Between CDW Corp and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CDW Corp and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CDW Corp and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CDW Corp and Spyre Therapeutics, you can compare the effects of market volatilities on CDW Corp and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CDW Corp with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CDW Corp and Spyre Therapeutics.

Diversification Opportunities for CDW Corp and Spyre Therapeutics

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between CDW and Spyre is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding CDW Corp and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and CDW Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CDW Corp are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of CDW Corp i.e., CDW Corp and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between CDW Corp and Spyre Therapeutics

Considering the 90-day investment horizon CDW Corp is expected to generate 0.43 times more return on investment than Spyre Therapeutics. However, CDW Corp is 2.31 times less risky than Spyre Therapeutics. It trades about 0.33 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  17,328  in CDW Corp on October 20, 2024 and sell it today you would earn a total of  1,545  from holding CDW Corp or generate 8.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

CDW Corp  vs.  Spyre Therapeutics

 Performance 
       Timeline  
CDW Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CDW Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

CDW Corp and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CDW Corp and Spyre Therapeutics

The main advantage of trading using opposite CDW Corp and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CDW Corp position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind CDW Corp and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes